Ballesteros-Monrreal Manuel G, Mendez-Pfeiffer Pablo, Barrios-Villa Edwin, Arenas-Hernández Margarita M P, Enciso-Martínez Yessica, Sepúlveda-Moreno César O, Bolado-Martínez Enrique, Valencia Dora
Departamento de Ciencias Químico-Biológicas y Agropecuarias, Universidad de Sonora, H. Caborca, Sonora, México.
Posgrado en Microbiología, Centro de Investigación en Ciencias Microbiológicas, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Ciudad Universitaria, Puebla, Pue, México.
Arch Med Res. 2023 Apr;54(3):247-260. doi: 10.1016/j.arcmed.2023.01.001. Epub 2023 Jan 30.
Urinary tract infections (UTI) are one of the most common pathologies in Mexico and the majority are caused by uropathogenic Escherichia coli (UPEC). UPEC possesses virulence and resistance determinants that promote UTI development and affect diagnosis and treatment. This study aims to systematically review published reports of virulence genes, antibiotic resistance, and phylogenetic groups prevalent in clinical isolates of UPEC in the Mexican population.
Systematic review with meta-analysis was performed following PRISMA guidelines. Articles in both English and Spanish were included. Total prevalence with a 95% confidence interval of each characteristic was calculated. Heterogeneity between studies and geographical areas was assessed by the Cochran Q test (Q), I-square (I), and H-square (H). Egger's test was used for risk of bias in publications and asymmetry evaluations.
Forty-two articles were analyzed. The most prevalent virulence genes were ecp (97.25%; n = 364) and fimH (82.34%; n = 1,422), which are associated with lower UTI, followed by papGII (40.98%; n = 810), fliC (38.87%; n = 319), hlyA (23.55%; n = 1,521), responsible for with upper UTI. More than 78.13% (n = 1,893) of the isolates were classified as multidrug-resistant, with a higher prevalence of resistance to those antibiotics that are implemented in the basic regimen in Mexico. The most frequently reported Extended Spectrum β-Lactamase (ESBL) was CTX-M-1 (55.61%; n = 392), and the predominant phylogroup was B2 (35.94%; n = 1,725).
UPEC strains are responsible for a large portion of both lower and upper UTI in Mexico, and their multi-drug resistance drastically reduces the number of therapeutic options available.
尿路感染(UTI)是墨西哥最常见的病症之一,大多数由尿路致病性大肠杆菌(UPEC)引起。UPEC具有促进UTI发展并影响诊断和治疗的毒力和耐药性决定因素。本研究旨在系统回顾已发表的关于墨西哥人群中UPEC临床分离株中普遍存在的毒力基因、抗生素耐药性和系统发育组的报告。
按照PRISMA指南进行系统回顾和荟萃分析。纳入英文和西班牙文的文章。计算每个特征的总患病率及95%置信区间。通过Cochran Q检验(Q)、I方(I)和H方(H)评估研究和地理区域之间的异质性。使用Egger检验评估出版物中的偏倚风险和不对称性。
分析了42篇文章。最普遍的毒力基因是ecp(97.25%;n = 364)和fimH(82.34%;n = 1422),它们与下尿路感染有关,其次是与上尿路感染有关的papGII(40.98%;n = 810)、fliC(38.87%;n = 319)、hlyA(23.55%;n = 1521)。超过78.13%(n = 1893)的分离株被归类为多重耐药,对墨西哥基本治疗方案中使用的那些抗生素的耐药率更高。最常报道的超广谱β-内酰胺酶(ESBL)是CTX-M-1(55.61%;n = 392),主要系统发育组是B2(35.94%;n = 1725)。
UPEC菌株是墨西哥下尿路感染和上尿路感染的主要病因,其多重耐药性大大减少了可用的治疗选择数量。